CASTLE BIOSCIENCES INC Quarterly Operating Income (Loss) in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Castle Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
  • Castle Biosciences Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $5.08M.
  • Castle Biosciences Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.04M, a 98.8% increase year-over-year.
  • Castle Biosciences Inc annual Operating Income (Loss) for 2023 was -$68M, a 6.7% increase from 2022.
  • Castle Biosciences Inc annual Operating Income (Loss) for 2022 was -$72.9M, a 81.8% decline from 2021.
  • Castle Biosciences Inc annual Operating Income (Loss) for 2021 was -$40.1M, a 513% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.04M $5.08M +$14.7M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$15.8M $5.01M +$26.2M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 -$41.9M -$5.47M +$26.1M +82.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$68M -$5.66M +$17.2M +75.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$85.2M -$9.64M +$11.9M +55.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$97M -$21.2M -$17.2M -433% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 -$79.9M -$31.5M -$7.01M -28.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$72.9M -$22.8M -$7.66M -50.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$65.2M -$21.5M -$9.72M -82.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$55.5M -$3.97M +$4.84M +54.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$60.3M -$24.5M -$20.2M -472% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$40.1M -$15.2M -$12.1M -400% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$27.9M -$11.8M -$7.91M -203% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$20M -$8.81M -$8.17M -1266% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$11.9M -$4.28M -$5.32M -514% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$6.54M -$3.03M -$5.65M -216% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$897K -$3.9M -$8.33M -188% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $7.43M -$645K -$1.25M -206% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $8.69M $1.04M +$1.36M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $7.33M $2.61M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $4.43M +$7.28M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $608K +$3.27M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$322K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 -$2.85M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$2.67M Apr 1, 2018 Jun 30, 2018 10-Q 2019-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.